GlassScriptPhysician profile
Sounok Sen
NPI 1417394677
$34,020.38
in general payments reported to CMS, 2019-2025
6 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,457 · 2020: $324 · 2022: $133 · 2023: $31K · 2024: $538 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Consulting Fee: $10K · Food and Beverage: $1,077 · Travel and Lodging: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,204.49 |
| Consulting Fee | $10,400.00 |
| Food and Beverage | $1,076.90 |
| Travel and Lodging | $424.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $20,204.49 | 2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $11,471.95 | 2023-2025 | Camzyos |
| Amgen INC. | $1,456.60 | 2019 | |
| Abbott Laboratories | $506.24 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Regeneron Pharmaceuticals, INC. | $324.45 | 2020 | |
| Abiomed | $56.65 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sounok Sen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.